MMB Healthcare
FDA Approved Drugs

MMB Healthcare

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 10
  • Latest Approval Date Dec 21, 2015
  • Data Source FDA
  • First Approval Date Jun 30, 2011
Company Overview

Company

MMB Healthcare

Country

U.S.A

Website

Visit Website

Email

Social Profiles

Company Snapshot

MMB Healthcare

7079 Hunter Valley Dr, West Valley, Utah, 84128

U.S.A

mmbhealthcare.com/index.html View on Map
FDA Approved Drug Records ( 10 records )
2011
30 Jun
Discontinued Application: 22569

Drug Name

LAZANDA

Product Number

1

Dosage Form

-

Strength

EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-06-30

22569 / 1

Active Ingredient

FENTANYL CITRATE

Application Number

22569

Product Number

1

Dosage Form

-

Strength

EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-06-30

Regulatory Status

Discontinued

2011
30 Jun
Discontinued Application: 22569

Drug Name

LAZANDA

Product Number

2

Dosage Form

-

Strength

EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-06-30

22569 / 2

Active Ingredient

FENTANYL CITRATE

Application Number

22569

Product Number

2

Dosage Form

-

Strength

EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-06-30

Regulatory Status

Discontinued

2015
21 Dec
Discontinued Application: 22569

Drug Name

LAZANDA

Product Number

3

Dosage Form

-

Strength

EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2015-12-21

22569 / 3

Active Ingredient

FENTANYL CITRATE

Application Number

22569

Product Number

3

Dosage Form

-

Strength

EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2015-12-21

Regulatory Status

Discontinued

2012
04 Jan
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

1

Dosage Form

-

Strength

0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

202788 / 1

Active Ingredient

FENTANYL

Application Number

202788

Product Number

1

Dosage Form

-

Strength

0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

Regulatory Status

Discontinued

2012
04 Jan
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

2

Dosage Form

-

Strength

0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

202788 / 2

Active Ingredient

FENTANYL

Application Number

202788

Product Number

2

Dosage Form

-

Strength

0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

Regulatory Status

Discontinued

2012
04 Jan
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

3

Dosage Form

-

Strength

0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

202788 / 3

Active Ingredient

FENTANYL

Application Number

202788

Product Number

3

Dosage Form

-

Strength

0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

Regulatory Status

Discontinued

2012
04 Jan
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

4

Dosage Form

-

Strength

0.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

202788 / 4

Active Ingredient

FENTANYL

Application Number

202788

Product Number

4

Dosage Form

-

Strength

0.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

Regulatory Status

Discontinued

2012
04 Jan
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

5

Dosage Form

-

Strength

0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

202788 / 5

Active Ingredient

FENTANYL

Application Number

202788

Product Number

5

Dosage Form

-

Strength

0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-01-04

Regulatory Status

Discontinued

2012
30 Aug
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

6

Dosage Form

-

Strength

1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-08-30

202788 / 6

Active Ingredient

FENTANYL

Application Number

202788

Product Number

6

Dosage Form

-

Strength

1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-08-30

Regulatory Status

Discontinued

2012
30 Aug
Discontinued Application: 202788

Drug Name

SUBSYS

Product Number

7

Dosage Form

-

Strength

1.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-08-30

202788 / 7

Active Ingredient

FENTANYL

Application Number

202788

Product Number

7

Dosage Form

-

Strength

1.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2012-08-30

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    10 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
10 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

LAZANDA

Application Number

22569

Product Number

1

Active Ingredient

FENTANYL CITRATE

Dosage Form

-

Strength

EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit